NO20054102L - Vaksiner avledet fra epitelial celle mucin Muc-1 - Google Patents

Vaksiner avledet fra epitelial celle mucin Muc-1

Info

Publication number
NO20054102L
NO20054102L NO20054102A NO20054102A NO20054102L NO 20054102 L NO20054102 L NO 20054102L NO 20054102 A NO20054102 A NO 20054102A NO 20054102 A NO20054102 A NO 20054102A NO 20054102 L NO20054102 L NO 20054102L
Authority
NO
Norway
Prior art keywords
epithelial cell
muc
vaccines derived
cell mucin
mucin muc
Prior art date
Application number
NO20054102A
Other languages
English (en)
Norwegian (no)
Other versions
NO20054102D0 (no
Inventor
Paul A Hamblin
Maria De Los Angeles Roch Cura
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20054102D0 publication Critical patent/NO20054102D0/no
Publication of NO20054102L publication Critical patent/NO20054102L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4727Mucins, e.g. human intestinal mucin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20054102A 2003-02-28 2005-09-02 Vaksiner avledet fra epitelial celle mucin Muc-1 NO20054102L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0304634.9A GB0304634D0 (en) 2003-02-28 2003-02-28 Vaccines
PCT/EP2004/002007 WO2004076665A2 (en) 2003-02-28 2004-02-26 Vaccines derived from epithelial cell mucin muc-1

Publications (2)

Publication Number Publication Date
NO20054102D0 NO20054102D0 (no) 2005-09-02
NO20054102L true NO20054102L (no) 2005-09-27

Family

ID=9953871

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054102A NO20054102L (no) 2003-02-28 2005-09-02 Vaksiner avledet fra epitelial celle mucin Muc-1

Country Status (18)

Country Link
US (1) US20060147458A1 (es)
EP (1) EP1597368A2 (es)
JP (1) JP2007524352A (es)
KR (1) KR20050107472A (es)
CN (1) CN1753994A (es)
AU (1) AU2004215187A1 (es)
BR (1) BRPI0407601A (es)
CA (1) CA2517062A1 (es)
CO (1) CO5670372A2 (es)
GB (1) GB0304634D0 (es)
IS (1) IS7956A (es)
MA (1) MA27746A1 (es)
MX (1) MXPA05009160A (es)
NO (1) NO20054102L (es)
PL (1) PL378761A1 (es)
RU (1) RU2005125608A (es)
WO (1) WO2004076665A2 (es)
ZA (1) ZA200506548B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0617387D0 (en) * 2006-09-04 2006-10-11 Glaxo Group Ltd Synthetic gene
CN103570821A (zh) * 2012-07-27 2014-02-12 北京智飞绿竹生物制药有限公司 粘蛋白-1抗原性多肽及其作为肿瘤疫苗的用途
JP7062003B2 (ja) 2016-09-28 2022-05-02 バヴァリアン・ノルディック・アクティーゼルスカブ ポックスウイルス内における導入遺伝子の安定性を向上させるための組成物及び方法
CN114230655A (zh) * 2021-03-24 2022-03-25 深圳市新靶向生物科技有限公司 一种与食道癌驱动基因突变相关的抗原肽组合及其应用
WO2023122526A1 (en) * 2021-12-20 2023-06-29 Zoetis Services Llc Use of interferon as an adjuvant in vaccines

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPM322393A0 (en) * 1993-12-24 1994-01-27 Austin Research Institute, The Mucin carbohydrate compounds and their use in immunotherapy
US6548643B1 (en) * 1994-11-16 2003-04-15 Austin Research Institute Antigen carbohydrate compounds and their use in immunotherapy
IL125608A0 (en) * 1998-07-30 1999-03-12 Yeda Res & Dev Tumor associated antigen peptides and use of same as anti-tumor vaccines
DE60030450T2 (de) * 1999-09-08 2007-08-30 Transgene S.A. Von MUC-1 abgeleitete Peptide
GB9930359D0 (en) * 1999-12-22 2000-02-09 Glaxo Group Ltd Novel polypeptides
WO2001057068A1 (en) * 2000-02-01 2001-08-09 The Austin Research Institute Mucin-1 derived antigens and their use in immunotherapy
GB0212036D0 (en) * 2002-05-24 2002-07-03 Glaxo Group Ltd Vaccines
GB0212046D0 (en) * 2002-05-24 2002-07-03 Glaxo Group Ltd Vaccines
GB0321614D0 (en) * 2003-09-15 2003-10-15 Glaxo Group Ltd Vaccines

Also Published As

Publication number Publication date
BRPI0407601A (pt) 2006-02-14
JP2007524352A (ja) 2007-08-30
GB0304634D0 (en) 2003-04-02
US20060147458A1 (en) 2006-07-06
CA2517062A1 (en) 2004-09-10
CN1753994A (zh) 2006-03-29
IS7956A (is) 2005-07-25
PL378761A1 (pl) 2006-05-15
NO20054102D0 (no) 2005-09-02
WO2004076665A3 (en) 2005-02-24
RU2005125608A (ru) 2006-03-27
WO2004076665A2 (en) 2004-09-10
MXPA05009160A (es) 2005-10-20
CO5670372A2 (es) 2006-08-31
EP1597368A2 (en) 2005-11-23
ZA200506548B (en) 2007-12-27
MA27746A1 (fr) 2006-02-01
AU2004215187A1 (en) 2004-09-10
KR20050107472A (ko) 2005-11-11

Similar Documents

Publication Publication Date Title
CY1122532T1 (el) Παραλλαγες πολυπεπτιδιου ρη20, σκευασματα και χρησεις αυτων
ATE362932T1 (de) Azaindolverbindungen als kinaseinhibitoren
NO20082716L (no) Sammensetninger og fremgangsmater for fremstilling av en sammensetning
UA112281C2 (uk) Стабільні інсектицидні композиції і способи їх отримання
BR112012007692A2 (pt) planta, ácido nucleico isolado, e, métodos para gerar uma planta haploide e para preparar uma planta
BR112012013193A2 (pt) composição oral contendo zizyphus joazeiro e métodos relacionados
BR112015018508A2 (pt) moduladores de enzimas modificadoras de metila, suas composições e uso
CY1113282T1 (el) Αντιικα νουκλεοζιτικα αναλογα
NO20054102L (no) Vaksiner avledet fra epitelial celle mucin Muc-1
IT1402650B1 (it) Procedimento per preparare da se' il pane, macchina per il pane e relativa scatola di ingredienti per il pane.
EA201190306A1 (ru) Улучшенная липидная композиция
BR112015014502A2 (pt) composições para higiene oral contendo haletos de zinco-aminoácidos
ECSP109987A (es) Métodos y compuestos útiles para preparar inhibidores del co-transportador 2 sodio glucosa
NO20062709L (no) Stamceller som er egnet for transplantasjon, fremstilling derav og farmasoytiske preperater omfattende nevnte stamceller
MX2009004862A (es) Estabilizacion de vacunas por liofilizacion.
TW200609221A (en) 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them
UA86591C2 (ru) Пирролодигидроизохинолины как ингибиторы pde10, фармацевтическая композиция на их основе
MA32363B1 (fr) Composition pharmaceutique comprenant un sel de strontium, de la vitamine d et une cyclodextrine.
DOP2011000319A (es) Formulaciones liquidas de sales de 1-[2-(2,4- dimetilfenilsulfanil)-fenil]-piperazina
MX2010003200A (es) Composiciones de imatibnib estables.
BR112015021993A2 (pt) composições de cultura celular com antioxidantes e métodos para produção de polipeptídeo
MX2009010103A (es) Composiciones estructuradas que comprenden una arcilla.
MX2013003152A (es) Composiciones de bepotastina.
PA8792401A1 (es) Fenilendiaminas
NO20081470L (no) Polypeptider som har antimikrobeaktivitet og polynukleotider som koder for disse.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application